Federal grants to Cancer Targeted Technology LLC
Cancer Targeted Technology LLC in Pullman, Washington received $4.8 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Cancer Treatment Research, with $3.8 million. In fiscal 2025 it was awarded $2.0 million.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$4.8 million
- Awards4
- Awarded in FY 2025$2.0 million
- Largest award$2.4 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 2 | $1.4 million |
| FY 2022 | 1 | $999,998 |
| FY 2023 | 0 | $0 |
| FY 2024 | 1 | $400,000 |
| FY 2025 | 1 | $2.0 million |
Programs that fund Cancer Targeted Technology LLC
| Program | Awards | Amount |
|---|---|---|
| Cancer Treatment Research | 3 | $3.8 million |
| Cancer Cause and Prevention Research | 1 | $999,998 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 4 | $4.8 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Development of an innovative psma-targeted small molecule prodrug for prostate cancer - abstract prostate cancer (PCA) is the most commonly diagnosed cancer and second leading cause of cancer death in american men.1 for metastatic castration resistant prostate cancer (MCRPC), therapeutic options inc | Cancer Treatment Research | September 2, 2024 | $2.4 million |
| Development of a commercial-ready kit for CTT1403, a novel psma-targeted radiotherapy - project abstract prostate-specific membrane antigen (PSMA) is an ideal tumor biomarker with specific expression on >90% of all prostate cancers that increases with disease progression. Cancer targeted technology | Cancer Treatment Research | September 20, 2021 | $1.0 million |
| Development of a commercial-ready kit for CTT1403, a novel psma-targeted radiotherapy - project abstract prostate-specific membrane antigen (PSMA) is an ideal tumor biomarker with specific expression on >90% of all prostate cancers that increases with disease progression. Cancer targeted technology | Cancer Cause and Prevention Research | August 12, 2022 | $999,998 |
| Clinical evaluation of an innovative psma-targeted radiotherapy, CTT1403, in prostate cancer | Cancer Treatment Research | August 23, 2021 | $365,867 |
Questions people ask
How much federal grant money does Cancer Targeted Technology LLC get?
$4.8 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Cancer Targeted Technology LLC the most?
The Department of Health and Human Services, with $4.8 million in 4 awards.
What is Cancer Targeted Technology LLC's largest federal grant?
$2.4 million under Cancer Treatment Research, with its first action in the period on September 2, 2024. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Cancer Targeted Technology LLC?
Its largest are Cancer Treatment Research and Cancer Cause and Prevention Research.
Other grant recipients in Pullman
- Washington State University
- City of Pullman
- Washington State University
- Community Child Care Center
- Public Hospital District 1 a of Whitman County
- Palouse Conservation District
- Qualterra, Inc.
Largest federal grant recipients in Washington · Federal grants in Washington